61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A revenue 2002–2026What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
Genmab A/S ADS's revenue in Q3 FY2026, the three months to 30 September 2026, was 1.19B USD, up 16.1% on the same quarter a year before. Genmab A/S ADS's revenue over the last twelve months was 4.30B USD, down 49.4% on the twelve months before. In fiscal year 2025 it was 3.72B USD, down 82.7% on the year before.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 4.30B | -49.42% | 3.98B | 729.10M |
| FY2025 | 31 Dec 2025 | 3.72B | -82.70% | 3.41B | 963.76M |
| FY2024 | 31 Dec 2024 | 21.53B | +30.67% | 20.54B | 7.84B |
| FY2023 | 31 Dec 2023 | 16.47B | +13.57% | 16.25B | 4.35B |
| FY2022 | 31 Dec 2022 | 14.51B | +72.33% | 14.51B | 5.45B |
| FY2021 | 31 Dec 2021 | 8.42B | -16.75% | 8.42B | 2.96B |
| FY2020 | 31 Dec 2020 | 10.11B | +88.43% | 10.11B | 4.76B |
| FY2019 | 31 Dec 2019 | 5.37B | +77.38% | 5.37B | 2.17B |
| FY2018 | 31 Dec 2018 | 3.03B | +27.89% | 3.03B | 1.47B |
| FY2017 | 31 Dec 2017 | 2.37B | +30.25% | 2.37B | 1.10B |
| FY2016 | 31 Dec 2016 | 1.82B | +60.29% | 1.82B | 1.19B |
| FY2015 | 31 Dec 2015 | 1.13B | +33.24% | 1.13B | 763.51M |
| FY2014 | 31 Dec 2014 | 850.39M | +28.15% | 850.39M | 301.30M |
| FY2013 | 31 Dec 2013 | 663.57M | +36.92% | 663.57M | 112.36M |
| FY2012 | 31 Dec 2012 | 484.64M | +38.10% | 484.64M | -487.12M |
| FY2011 | 31 Dec 2011 | 350.94M | -39.71% | -181.57M | -596.37M |
| FY2010 | 31 Dec 2010 | 582.08M | -0.68% | -435.00K | -321.46M |
| FY2009 | 31 Dec 2009 | 586.08M | -15.34% | 586.08M | -1.01B |
| FY2008 | 31 Dec 2008 | 692.30M | +30.74% | 696.30M | -965.09M |
| FY2007 | 31 Dec 2007 | 529.54M | +290.67% | 529.54M | -383.37M |
| FY2006 | 31 Dec 2006 | 135.55M | +37.60% | 135.55M | -438.24M |
| FY2005 | 31 Dec 2005 | 98.51M | +2,301.98% | 98.51M | -393.59M |
| FY2004 | 31 Dec 2004 | 4.10M | -94.00% | 4.10M | -415.21M |
| FY2003 | 31 Dec 2003 | 68.33M | — | 68.33M | -327.11M |
| FY2002 | 31 Dec 2002 | 0.00 | — | 0.00 | -479.33M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.19B | +16.14% | 1.10B | 342.00M |
| Q2 FY2026 | 30 Jun 2026 | 1.16B | +24.89% | 1.07B | 303.00M |
| Q1 FY2026 | 31 Mar 2026 | 899.32M | +754.59% | 834.08M | 53.20M |
| Q4 FY2025 | 31 Dec 2025 | 1.05B | -83.62% | 974.05M | 30.91M |
| Q3 FY2025 | 30 Sept 2025 | 1.02B | -81.55% | 964.00M | 401.00M |
| Q2 FY2025 | 30 Jun 2025 | 924.81M | -82.88% | 867.82M | 335.93M |
| Q1 FY2025 | 31 Mar 2025 | 105.23M | -82.55% | 99.05M | 28.70M |
| Q4 FY2024 | 31 Dec 2024 | 6.44B | +37.69% | 6.10B | 3.85B |
| Q3 FY2024 | 30 Sept 2024 | 5.54B | +17.57% | 5.27B | 1.27B |
| Q2 FY2024 | 30 Jun 2024 | 5.40B | +29.58% | 751.00M | 203.00M |
| Q1 FY2024 | 31 Mar 2024 | 603.00M | -78.72% | 576.00M | 192.00M |
| Q4 FY2023 | 31 Dec 2023 | 4.68B | -8.94% | 4.55B | 640.00M |
| Q3 FY2023 | 30 Sept 2023 | 4.71B | +15.29% | 4.63B | 2.10B |
| Q2 FY2023 | 30 Jun 2023 | 4.17B | +31.85% | 4.15B | 1.34B |
| Q1 FY2023 | 31 Mar 2023 | 2.83B | +33.74% | 2.83B | 210.00M |
| Q4 FY2022 | 31 Dec 2022 | 5.14B | +96.14% | 5.14B | 514.00M |
| Q3 FY2022 | 30 Sept 2022 | 4.09B | +76.93% | 4.09B | 2.58B |
| Q2 FY2022 | 30 Jun 2022 | 3.16B | +60.34% | 3.16B | 1.89B |
| Q1 FY2022 | 31 Mar 2022 | 2.12B | +34.03% | 2.12B | 465.00M |
| Q4 FY2021 | 31 Dec 2021 | 2.62B | +28.13% | 2.62B | 716.00M |
| Q3 FY2021 | 30 Sept 2021 | 2.31B | +33.99% | 2.31B | 890.00M |
| Q2 FY2021 | 30 Jun 2021 | 1.97B | -63.82% | 1.97B | 306.00M |
| Q1 FY2021 | 31 Mar 2021 | 1.58B | +77.24% | 1.58B | 1.10B |
| Q4 FY2020 | 31 Dec 2020 | 2.04B | -30.97% | 2.04B | 581.00M |
| Q3 FY2020 | 30 Sept 2020 | 1.72B | +65.79% | 1.72B | 530.00M |
| Q2 FY2020 | 30 Jun 2020 | 5.45B | +604.34% | 5.45B | 3.38B |
| Q1 FY2020 | 31 Mar 2020 | 892.00M | +50.93% | 892.00M | 269.00M |
| Q4 FY2019 | 31 Dec 2019 | 2.96B | +139.61% | 2.96B | 1.47B |
| Q3 FY2019 | 30 Sept 2019 | 1.04B | +73.71% | 1.04B | 537.00M |
| Q2 FY2019 | 30 Jun 2019 | 773.91M | +51.84% | 773.91M | 85.00M |
| Q1 FY2019 | 31 Mar 2019 | 591.01M | -13.22% | 591.01M | 72.00M |
| Q4 FY2018 | 31 Dec 2018 | 1.24B | +21.42% | 1.24B | 833.87M |
| Q3 FY2018 | 30 Sept 2018 | 598.60M | +85.07% | 598.60M | 179.18M |
| Q2 FY2018 | 30 Jun 2018 | 509.68M | -34.09% | 509.68M | 260.53M |
| Q1 FY2018 | 31 Mar 2018 | 681.01M | +171.56% | 681.01M | 198.57M |
| Q4 FY2017 | 31 Dec 2017 | 1.02B | +9.75% | 1.02B | 785.87M |
| Q3 FY2017 | 30 Sept 2017 | 323.45M | -11.30% | 323.45M | -5.68M |
| Q2 FY2017 | 30 Jun 2017 | 773.35M | +118.57% | 773.35M | 307.27M |
| Q1 FY2017 | 31 Mar 2017 | 250.78M | +47.37% | 250.78M | 16.10M |
| Q4 FY2016 | 31 Dec 2016 | 927.46M | +61.39% | 927.46M | 841.41M |
| Q3 FY2016 | 30 Sept 2016 | 364.66M | +31.29% | 364.66M | 188.96M |
| Q2 FY2016 | 30 Jun 2016 | 353.83M | +103.53% | 353.83M | 168.23M |
| Q1 FY2016 | 31 Mar 2016 | 170.17M | +59.37% | 170.17M | -11.53M |
| Q4 FY2015 | 31 Dec 2015 | 574.66M | +166.29% | 574.66M | 389.47M |
| Q3 FY2015 | 30 Sept 2015 | 277.77M | +2.30% | 277.77M | 140.27M |
| Q2 FY2015 | 30 Jun 2015 | 173.84M | +49.88% | 173.84M | 16.49M |
| Q1 FY2015 | 31 Mar 2015 | 106.78M | -56.78% | 106.78M | 217.29M |
| Q4 FY2014 | 31 Dec 2014 | 215.80M | -0.11% | 215.80M | 69.02M |
| Q3 FY2014 | 30 Sept 2014 | 271.52M | +81.42% | 271.52M | 159.92M |
| Q2 FY2014 | 30 Jun 2014 | 115.99M | -16.01% | 115.99M | -26.15M |
| Q1 FY2014 | 31 Mar 2014 | 247.07M | +54.64% | 247.07M | 98.50M |
| Q4 FY2013 | 31 Dec 2013 | 216.04M | +32.46% | 216.04M | 59.87M |
| Q3 FY2013 | 30 Sept 2013 | 149.66M | +29.16% | 149.66M | 5.34M |
| Q2 FY2013 | 30 Jun 2013 | 138.09M | +23.69% | 138.09M | -25.34M |
| Q1 FY2013 | 31 Mar 2013 | 159.78M | +69.96% | 159.78M | 72.49M |
| Q4 FY2012 | 31 Dec 2012 | 163.10M | +75.25% | 163.10M | -359.80M |
| Q3 FY2012 | 30 Sept 2012 | 115.88M | +27.52% | 115.88M | -55.77M |
| Q2 FY2012 | 30 Jun 2012 | 111.65M | +33.11% | -21.15M | -2.08M |
| Q1 FY2012 | 31 Mar 2012 | 94.01M | +13.10% | -29.04M | -69.48M |
| Q4 FY2011 | 31 Dec 2011 | 93.07M | +2.10% | -49.13M | -43.81M |
| Q3 FY2011 | 30 Sept 2011 | 90.87M | -57.66% | -40.42M | -360.77M |
| Q2 FY2011 | 30 Jun 2011 | 83.88M | -50.60% | -47.67M | -80.57M |
| Q1 FY2011 | 31 Mar 2011 | 83.12M | -21.97% | -44.36M | -111.22M |
| Q4 FY2010 | 31 Dec 2010 | 91.16M | -52.74% | -57.20M | -83.91M |
| Q3 FY2010 | 30 Sept 2010 | 214.60M | +210.89% | 193.71M | -18.45M |
| Q2 FY2010 | 30 Jun 2010 | 169.80M | +128.93% | -23.26M | -88.69M |
| Q1 FY2010 | 31 Mar 2010 | 106.52M | -57.39% | -113.68M | -130.41M |
| Q4 FY2009 | 31 Dec 2009 | 192.90M | — | 192.90M | -607.61M |
| Q3 FY2009 | 30 Sept 2009 | 69.03M | — | -107.91M | -89.55M |
| Q2 FY2009 | 30 Jun 2009 | 74.17M | — | — | -114.45M |
| Q1 FY2009 | 31 Mar 2009 | 249.98M | — | — | -199.16M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Genmab A's revenue
Source: Financial Modeling Prep